Prognostic value of systemic inflammation in patients undergoing 1st-line chemotherapy for metastatic pancreatic cancer: Tokushukai REAl-world Data project

被引：0
|
作者：
Shimoyama, Rai [1 ]
Imamura, Yoshinori [2 ]
Uryu, Kiyoaki [3 ]
Mase, Takahiro [4 ]
Fujimura, Yoshiaki [5 ]
Hayashi, Maki [6 ]
Ohtaki, Megu [7 ]
Ohtani, Keiko [7 ]
Shinozaki, Nobuaki [1 ,8 ]
Minami, Hironobu [2 ]
机构：
[1] Shonankamakura Gen Hosp, Dept Gen Surg, Kamakura, Kanagawa, Japan
[2] Kobe Univ, Grad Sch Med, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan
[3] Yao Tokushukai Hosp, Dept Resp Med & Oncol, Yao, Japan
[4] Ogaki Tokushukai Hosp, Dept Breast Surg, Ogaki, Japan
[5] Tokushukai Informat Syst Inc, Osaka, Japan
[6] Irai Iryo Res Ctr Inc, Kashiwa, Chiba, Japan
[7] deCult Co Ltd, Kurashiki, Okayama, Japan
[8] Gen Inc Assoc Tokushukai, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.340
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10-2
引用
收藏
页码：S1445 / S1446
页数：2
相关论文
共 50 条
  • [41] Pembrolizumab in Combination with Chemotherapy for Patients with metastatic NSCLC: An Analysis using Real-World Data from the National Clinical Cancer Registry
    Haberlin, J.
    Kanz, F.
    Surovtsova, I
    Morakis, P.
    PNEUMOLOGIE, 2024, 78 : S100 - S101
  • [42] Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real-world study
    Hang, Junjie
    Wu, Lixia
    Zhu, Lina
    Sun, Zhiqiang
    Wang, Ge
    Pan, Jingjing
    Zheng, Suhua
    Xu, Kequn
    Du, Jiadi
    Jiang, Hua
    CANCER MEDICINE, 2018, 7 (07): : 2974 - 2984
  • [43] Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice
    Mencinger, Marina
    Mangaroski, Dusan
    Bokal, Urska
    RADIOLOGY AND ONCOLOGY, 2021, 55 (04) : 491 - 498
  • [44] Comparison of real-world mortality data among patients with glioblastoma (GBM) and metastatic pancreatic cancer (mPC) treated in the community oncology setting
    Cosgrove, David
    Aguilar, Kathleen
    Wang, Yunfei
    Sykes, Charles
    Reinwald, Sarah
    Kubisiak, Emily
    Su, Zhaohui
    Chandrasekaran, Vasu
    Stees, Larisa
    Iyer, Rupa
    Robert, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] CA19-9 Response to 1st-Line Neoadjuvant FOLFIRINOX and 2nd-Line Gemcitabine-Based Chemotherapy in Patients with Operable Pancreatic Cancer
    Thalji, S.
    Kamgar, M.
    George, B.
    Aldakkak, M.
    Christians, K.
    Clarke, C. N.
    Erickson, B.
    Hall, W.
    Tolat, P.
    Khan, A.
    Evans, D. B.
    Tsai, S.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S20 - S20
  • [46] Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study
    Wan, Chao-Ling
    Huang, Yuan-Hong
    Huang, Si-Man
    Xu, Yan-Li
    Tan, Kai-Wen
    Yan-Qiu
    Shen, Xiang-Dong
    Ge, Shuai-Shuai
    Cao, Han-Yu
    Li, Yan-Yan
    Liu, Song-Bai
    Qi, Jia-Jun
    Dai, Hai-Ping
    Xue, Sheng-Li
    LEUKEMIA RESEARCH, 2024, 139
  • [47] Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World Study
    Francois, Eric
    Mineur, Laurent
    Deplanque, Gael
    Laplaige, Philippe
    Smith, Denis
    Gourgou, Sophie
    Tanang, Alexandre
    Ionescu-Goga, Miruna
    Veerabudun, Kalaivani
    Lelarge, Yoann
    Kim, Stefano
    Rollot, Florence
    CLINICAL COLORECTAL CANCER, 2020, 19 (03) : E100 - E109
  • [48] Real-world prevalence of adverse events with first-line systemic therapies among patients with metastatic castration-sensitive prostate cancer
    Swami, Umang
    Xie, Bin
    Young, Christopher
    Ramaswamy, Krishnan
    El-Chaar, Nader
    Gao, Wei
    Yang, Hongbo
    Wang, Yao
    Mucha, Lisa
    PROSTATE, 2024,
  • [49] Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1
    Uryu, Kiyoaki
    Imamura, Yoshinori
    Shimoyama, Rai
    Mase, Takahiro
    Fujimura, Yoshiaki
    Hayashi, Maki
    Ohtaki, Megu
    Otani, Keiko
    Hibino, Makoto
    Horiuchi, Shigeto
    Fukui, Tomoya
    Fukai, Ryuta
    Chihara, Yusuke
    Iwase, Akihiko
    Yamada, Noriko
    Tamura, Yukihiro
    Harada, Hiromasa
    Shinozaki, Nobuaki
    Shimada, Toyoshi
    Tsuya, Asuka
    Fukuoka, Masahiro
    Minami, Hironobu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (02) : 197 - 208
  • [50] Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data
    Koen Degeling
    Hui-Li Wong
    Hendrik Koffijberg
    Azim Jalali
    Jeremy Shapiro
    Suzanne Kosmider
    Rachel Wong
    Belinda Lee
    Matthew Burge
    Jeanne Tie
    Desmond Yip
    Louise Nott
    Adnan Khattak
    Stephanie Lim
    Susan Caird
    Peter Gibbs
    Maarten IJzerman
    PharmacoEconomics, 2020, 38 : 1263 - 1275
12345